| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $17.4B | $16.9B | $17.2B | $17.5B | $15.7B | $3.2B | $3.0B |
| Cost of Revenue | $9.2B | $9.5B | $9.9B | $10.4B | $9.2B | $2.1B | $2.0B |
| Gross Profit | — | — | — | — | — | — | — |
| R&D Expense | $1.5B | $1.4B | $1.3B | $1.2B | $1.2B | $1.1B | $1.1B |
| SG&A Expense | $3.5B | $3.2B | $3.2B | $3.2B | $3.2B | $3.0B | $3.1B |
| Operating Income | — | — | — | — | — | — | — |
| Net Income | $1.1B | $0.9B | $0.7B | $1.1B | $1.8B | $0.0B | $-0.0B |
| EPS (Basic) | $1.60 | $1.31 | $1.04 | $1.59 | $2.39 | $0.91 | $-1.28 |
| EPS (Diluted) | $1.60 | $1.30 | $1.03 | $1.58 | $2.37 | $0.91 | $-1.28 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $42.8B | $40.8B | $43.0B | $42.6B | $42.3B | $42.6B | $42.4B |
| Current Assets | $17.3B | $15.1B | $16.3B | $16.8B | $15.5B | $14.8B | $13.5B |
| Cash & Equivalents | $4.5B | $3.1B | $2.6B | $3.2B | $4.5B | $3.5B | $1.8B |
| Total Liabilities | — | — | — | — | — | — | — |
| Current Liabilities | $12.1B | $10.4B | $10.4B | $10.7B | $9.6B | $8.5B | $8.2B |
| Stockholders' Equity | $24.1B | $23.8B | $25.0B | $25.3B | $25.4B | $24.8B | $24.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.4B | $2.1B | $1.8B | $0.9B | $2.7B | $2.1B | $1.1B |
| Investing Cash Flow | $-0.5B | $-0.6B | $-2.0B | $-0.6B | $-0.4B | $-0.7B | $-0.9B |
| Capital Expenditures | — | — | — | — | $1.2B | $1.2B | $1.2B |
| Financing Cash Flow | $-1.6B | $-1.2B | $-0.1B | $-1.2B | $-1.3B | $0.3B | $-2.9B |